Quantcast
Channel: Medical Xpress news tagged with:toxic material
Viewing all articles
Browse latest Browse all 7

Cancer drug shows promise in reducing toxic genetic material in myotonic dystrophy

$
0
0
A group of researchers has shown for the first time in cells and in a mouse model that a drug used to treat cancer can neutralize the toxic RNA that causes the prolonged muscle contractions and other symptoms of myotonic dystrophy type 1, the most common form of adult-onset muscular dystrophy. The researchers report their findings today Dec. 10, 2015 in the journal Cell Reports.

Viewing all articles
Browse latest Browse all 7

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>